Businesses
Independent Advisors
Book A Demo

 

Scitaris GmbH

 

A psychedelic renaissance for treating depression?

By Louise von Stechow, PhD, Head of Scientific Communications...

Read more

Research

K-Pharma, the Next Wave?

An Introduction to the Korean Pharmaceutical Sector - by Min...

Read more

Research

A race to vaccinate the world: An overview of COVID-19 vaccine status

Update on the COVID-19 vaccines mainly comparing the top 3 leader...

Read more

Research

Webcast : so now we have a vaccine, what's next?

3 Questions for the Scitaris team on the effectiveness of the...

Read more

Failure Due to High Placebo Response A Primer on Placebos in Clinical Trials and How to De-Risk Them

It is of critical importance for investors to understand the...

Read more

Research

Drug Pricing in the US - Current State and Potential Implications of the 2020 Presidential Election

By Jonas Hanske, PhD

Read more

Research

The Decade of Neuroscience? Opportunities & Caveats for Investors

During this years J.P. Morgen Healthcare Conference Roche Pharmaceuticals...

Read more

Research

COVID-19 - Biopharma’s agility put at test

Review of the active research on Covid-19 by leading Bio Pharma...

Read more

Research

At ReachX, we are accelerating the world's most ambitious projects and deals
The Platform
Our Vision
Our Team
Our Advisors
Resources
Login
T&Cs
 Privacy Policy
Cookies
Compliance
Press
120 Regent street W1B 5FE, London, United Kingdom - Company House: 11116510
Authorised and regulated by the FCA - Reference number 811226